{"id":"https://openalex.org/W2012339816","doi":"https://doi.org/10.1016/j.urolonc.2004.04.015","title":"Delivering prostate cancer prevention messages to the public: How the National Cancer Institute (NCI) effectively spread the word about the Prostate Cancer Prevention Trial (PCPT) results","display_name":"Delivering prostate cancer prevention messages to the public: How the National Cancer Institute (NCI) effectively spread the word about the Prostate Cancer Prevention Trial (PCPT) results","publication_year":2004,"publication_date":"2004-07-01","ids":{"openalex":"https://openalex.org/W2012339816","doi":"https://doi.org/10.1016/j.urolonc.2004.04.015","mag":"2012339816","pmid":"https://pubmed.ncbi.nlm.nih.gov/15283899"},"language":"en","primary_location":{"id":"doi:10.1016/j.urolonc.2004.04.015","doi":"https://doi.org/10.1016/j.urolonc.2004.04.015","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.urolonc.2004.04.015","pdf_url":null,"source":{"id":"https://openalex.org/S4802544","display_name":"Urologic Oncology Seminars and Original Investigations","issn_l":"1078-1439","issn":["1078-1439","1873-2496"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Urologic Oncology: Seminars and Original Investigations","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075884756","display_name":"Kara Smigel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Kara Smigel Croker","raw_affiliation_strings":["Division of Cancer Prevention, National Cancer Institute, 6130 Executive Boulevard, MSC 7315, Bethesda, MD 20892-7315, USA. smigelk@mail.nih.gov","Division of Cancer Prevention, National Cancer Institute, 6130 Executive Boulevard, MSC 7315, Bethesda, MD 20892-7315, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Cancer Prevention, National Cancer Institute, 6130 Executive Boulevard, MSC 7315, Bethesda, MD 20892-7315, USA. smigelk@mail.nih.gov","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"Division of Cancer Prevention, National Cancer Institute, 6130 Executive Boulevard, MSC 7315, Bethesda, MD 20892-7315, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111493862","display_name":"Anne Marie Ryan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anne Ryan","raw_affiliation_strings":["Division of Cancer Prevention, National Cancer Institute, 6130 Executive Boulevard, MSC 7315, Bethesda, MD 20892-7315, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Cancer Prevention, National Cancer Institute, 6130 Executive Boulevard, MSC 7315, Bethesda, MD 20892-7315, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085179726","display_name":"Thuy Morzenti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thuy Morzenti","raw_affiliation_strings":["Office of Communications, National Cancer Institute, 9000 Rockville Pike, MSC 2580, Bethesda, MD 20892-2580, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Office of Communications, National Cancer Institute, 9000 Rockville Pike, MSC 2580, Bethesda, MD 20892-2580, USA","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055654026","display_name":"Lynn Cave","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lynn Cave","raw_affiliation_strings":["Office of Communications, National Cancer Institute, 9000 Rockville Pike, MSC 2580, Bethesda, MD 20892-2580, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Office of Communications, National Cancer Institute, 9000 Rockville Pike, MSC 2580, Bethesda, MD 20892-2580, USA","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077655677","display_name":"Tamara Maze-Gallman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tamara Maze-Gallman","raw_affiliation_strings":["Office of Communications, National Cancer Institute, 9000 Rockville Pike, MSC 2580, Bethesda, MD 20892-2580, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Office of Communications, National Cancer Institute, 9000 Rockville Pike, MSC 2580, Bethesda, MD 20892-2580, USA","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5049889117","display_name":"Leslie G. Ford","orcid":"https://orcid.org/0000-0003-2412-8028","observed_orcids":["https://orcid.org/0000-0003-2412-8028"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leslie Ford","raw_affiliation_strings":["Division of Cancer Prevention, National Cancer Institute, 6130 Executive Boulevard, MSC 7315, Bethesda, MD 20892-7315, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Cancer Prevention, National Cancer Institute, 6130 Executive Boulevard, MSC 7315, Bethesda, MD 20892-7315, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5075884756"],"corresponding_institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"],"apc_list":{"value":3440,"currency":"USD","value_usd":3440},"apc_paid":null,"fwci":5.3754,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.95037268,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"22","issue":"4","first_page":"369","last_page":"376"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11121","display_name":"Public Relations and Crisis Communication","score":0.5648999810218811,"subfield":{"id":"https://openalex.org/subfields/3315","display_name":"Communication"},"field":{"id":"https://openalex.org/fields/33","display_name":"Social Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11121","display_name":"Public Relations and Crisis Communication","score":0.5648999810218811,"subfield":{"id":"https://openalex.org/subfields/3315","display_name":"Communication"},"field":{"id":"https://openalex.org/fields/33","display_name":"Social Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":0.11760000139474869,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12027","display_name":"Social Media in Health Education","score":0.10610000044107437,"subfield":{"id":"https://openalex.org/subfields/3306","display_name":"Health"},"field":{"id":"https://openalex.org/fields/33","display_name":"Social Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/prostate-cancer-prevention-trial","display_name":"Prostate Cancer Prevention Trial","score":0.9300000071525574},{"id":"https://openalex.org/keywords/finasteride","display_name":"finasteride","score":0.9390000104904175},{"id":"https://openalex.org/keywords/prostate-cancer-prevention","display_name":"prostate cancer prevention","score":0.9879999756813049},{"id":"https://openalex.org/keywords/health-communication","display_name":"health communication","score":0.6869999766349792},{"id":"https://openalex.org/keywords/national-cancer-institute","display_name":"National Cancer Institute","score":0.7639999985694885},{"id":"https://openalex.org/keywords/social-marketing","display_name":"social marketing","score":0.9480000138282776},{"id":"https://openalex.org/keywords/public-relations","display_name":"public relations","score":0.9869999885559082},{"id":"https://openalex.org/keywords/media-outreach","display_name":"media outreach","score":0.5090000033378601},{"id":"https://openalex.org/keywords/gleason-score","display_name":"Gleason score","score":0.5540000200271606}],"concepts":[{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.7824985980987549},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6512673497200012},{"id":"https://openalex.org/C2775884135","wikidata":"https://www.wikidata.org/wiki/Q845436","display_name":"Mandate","level":2,"score":0.606034517288208},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5675591230392456},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5337613224983215},{"id":"https://openalex.org/C138816342","wikidata":"https://www.wikidata.org/wiki/Q189603","display_name":"Public health","level":2,"score":0.5295879244804382},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.43059974908828735},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4221644997596741},{"id":"https://openalex.org/C2780234812","wikidata":"https://www.wikidata.org/wiki/Q1787013","display_name":"Cancer prevention","level":3,"score":0.41671133041381836},{"id":"https://openalex.org/C2775874879","wikidata":"https://www.wikidata.org/wiki/Q424167","display_name":"Finasteride","level":4,"score":0.413998544216156},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.39938265085220337},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.3581862449645996},{"id":"https://openalex.org/C2776235491","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate","level":3,"score":0.3526793122291565},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.305976539850235},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.18495503067970276},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.12368234992027283},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D003142","descriptor_name":"Communication","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003159","descriptor_name":"Community-Institutional Relations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006291","descriptor_name":"Health Policy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007255","descriptor_name":"Information Services","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009316","descriptor_name":"National Institutes of Health (U.S.)","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D010344","descriptor_name":"Patient Advocacy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D011639","descriptor_name":"Public Opinion","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011641","descriptor_name":"Public Relations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018120","descriptor_name":"Finasteride","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D040241","descriptor_name":"Social Marketing","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.urolonc.2004.04.015","doi":"https://doi.org/10.1016/j.urolonc.2004.04.015","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.urolonc.2004.04.015","pdf_url":null,"source":{"id":"https://openalex.org/S4802544","display_name":"Urologic Oncology Seminars and Original Investigations","issn_l":"1078-1439","issn":["1078-1439","1873-2496"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Urologic Oncology: Seminars and Original Investigations","raw_type":"journal-article"},{"id":"pmid:15283899","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15283899","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Urologic oncology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":7,"referenced_works":["https://openalex.org/W2044646650","https://openalex.org/W2058680827","https://openalex.org/W2133929387","https://openalex.org/W2141647078","https://openalex.org/W2164803063","https://openalex.org/W3135529189","https://openalex.org/W4214529620"],"related_works":["https://openalex.org/W2072976852","https://openalex.org/W2116740279","https://openalex.org/W2093593899","https://openalex.org/W2320480037","https://openalex.org/W2332791053","https://openalex.org/W2167607440","https://openalex.org/W9722579","https://openalex.org/W1580540686","https://openalex.org/W2068702388","https://openalex.org/W2064086420"],"abstract_inverted_index":null,"counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}